for an absolute risk reduction (ARR) of 1.28%, reported Andrew T. Chan, MD, MPH, of Massachusetts General Hospital and ...

Uncertainty regarding the effectiveness and safety of intensive low-density lipoprotein cholesterol (LDL-C) reduction in ...

The study revealed a lower risk of nephrolithiasis with SGLT2 inhibitors than DPP4 inhibitors in both stone never-formers and ...

Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

Adding the PCSK9 inhibitor led to greater absolute reductions in CVD risk than in younger patients, with no signs of safety ...

coronary revascularisation or hospitalisation for unstable angina – with a 25% relative risk reduction and a 4.8% absolute risk reduction in the first occurrence of major adverse cardiovascular ...

“We will be doing more studies that focus on individual diseases with several controls as well as looking at absolute risk reduction in different populations, in different subgroups as well.

The association between total physical activity/MVPA and T2D was similar across genetic risk strata but the absolute risk reduction from MVPA was the largest for those with high genetic risk. In ...